SPRY4 inhibits and sensitizes the primary KIT mutants in gastrointestinal stromal tumors (GISTs) to imatinib

作者：Shujing Li, Sien Zhao, Nianhai Liang, Shaoting Zhang, Liangying Zhang, Liangji Zhou, Anbu Liu, Xu Cao, Jinhai Tian, Yuanyuan Yu, Zhaoyang Fan, Kun Xiao, Ming Wang, Hui Zhao, Ru Bai, Jianmin Sun · 发表于：Gastric Cancer · 年份：2023 · DOI：10.1007/s10120-023-01402-4 · 被引用次数：9 · 研究领域：Gastrointestinal Tumor Research and Treatment、Sarcoma Diagnosis and Treatment、Mast cells and histamine